Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Intravenous Admixture Preparation Considerations, Part 7: Stability Issues

Author(s):  Allen Loyd V Jr

Issue:  Nov/Dec 2020 - Volume 24, Number 6
View All Articles in Issue

Page(s):  473-478

Intravenous Admixture Preparation Considerations, Part 7: Stability Issues Page 1
Intravenous Admixture Preparation Considerations, Part 7: Stability Issues Page 2
Intravenous Admixture Preparation Considerations, Part 7: Stability Issues Page 3
Intravenous Admixture Preparation Considerations, Part 7: Stability Issues Page 4
Intravenous Admixture Preparation Considerations, Part 7: Stability Issues Page 5
Intravenous Admixture Preparation Considerations, Part 7: Stability Issues Page 6

Download in electronic PDF format for $75

Abstract:  Preparation of intravenous admixtures is a critical component of pharmaceutical compounding, especially in hospitals and other healthcare facilities. In addition to the considerations already covered in this series, stability is very important to ensure the patient receives the appropriate intact and effective drug and dictates the quantity that can be prepared in advance and how long the admixture can be stored and administered effectively. This article discusses the different issues involved in the stability of intravenous admixtures and methods of avoiding instability issues.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, intravenous drug admixtures, chemical stability, physical stability, microbiological stability, instability, compatibility, incompatibility, parenteral preparations, antioxidants, chelating agents, synergists, hydrolysis, oxidation, photolysis, reduction, complexation, preservatives, surfactants, suspending agents, solvents, polymorphs, crystallization, vaporization, adsorption, large-volume parenteral containers, small-volume parenteral containers, ready-to-use parenteral products, storage conditions, shelf life, Q10 method, beyond-use dates

Related Categories: PARENTERALS, STABILITIES, COMPATIBILITIES, STERILE PREPARATIONS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Intravenous Admixture Preparation Considerations, Part 7: Stability Issues
Allen Loyd V Jr
Nov/Dec 2020
Pg. 473-478

Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved
Allen Loyd V Jr
Jan/Feb 2020
Pg. 44-50

Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation
Allen Loyd V Jr
Mar/Apr 2021
Pg. 131-139

Intravenous Admixture Preparation Considerations, Part 9-B: Error Prevention in Intravenous Admixture Preparation
Allen Loyd V Jr
May/Jun 2021
Pg. 222-229

Intravenous Admixture Preparation Considerations, Part 1: Overview of Series on Personnel Selection for Intravenous Admixture Compounding
Allen Loyd V Jr
Nov/Dec 2019
Pg. 478-482

Sterile Basics: Intravenous Admixture Preparation Considerations, Part 5: pH Considerations
Allen Loyd V Jr
Jul/Aug 2020
Pg. 305-309

Basics of Sterile Compounding: Sterile Basics of Compounding Intravenous Admixtures, Part 4: Physicochemical Considerations
Allen Loyd V Jr
Sep/Oct 2023
Pg. 397-409

Basics of Sterile Compounding: Intravenous Admixture Preparation Considerations, Part 10: Packaging and Container-closure Issues
Allen Loyd V Jr
Jul/Aug 2021
Pg. 311-317

Sterile Basics: Intravenous Admixture Compounding, Part 2: Parenteral Vehicle Considerations
Allen Loyd V Jr
May/Jun 2023
Pg. 223-229

Intravenous Admixture Preparation Considerations, Part 6: pH Considerations -- Applications
Allen Loyd V Jr
Sep/Oct 2020
Pg. 397-402

Intravenous Admixture Preparation Considerations, Part 8: Ready-to-Use Preparations
Allen Loyd V Jr
Jan/Feb 2021
Pg. 31-38

Intravenous Admixture Preparation Considerations, Part 3: Methods and Techniques to Decrease Incompatibilities
Allen Loyd V Jr
Mar/Apr 2020
Pg. 121-126

Sterile Basics: Intravenous Admixture Compounding, Part 1: Introduction and Overview of the General Guidelines for an Intravenous Admixture Compounding Program, and Compounding Personnel Considerations
Allen Loyd V Jr
Mar/Apr 2023
Pg. 123-139

Physicochemical Stability and Compatibility of Revefenacin (LAMA) and Formoterol Fumarate (LABA) Inhalation Solution Admixture
Ngim Kenley
, Patel Jalpa
May/Jun 2020
Pg. 242-245

Intravenous Physical Compatibility of Heparin Sodium and Furosemide
Maktabi Briana
, Howard Mitchell S, Baki Gabriella, Churchwell Mariann D
Nov/Dec 2022
Pg. 522-526

Investigation of the Physical, Chemical, and Microbiological Stability of Oral Solutions Compounded with Herbals
Khokhlova Kateryna O
, Zdoryk Oleksandr A
May/Jun 2018
Pg. 240-246

Sterile Basics of Compounding: Intravenous Admixture Compounding, Part 3: Preparation Procedures
Allen Loyd V Jr
Jul/Aug 2023
Pg. 305-313

Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates
Allen Loyd V Jr
May/Jun 2020
Pg. 215-220

Physical and Chemical Stability of Pharmaceutical Preparation of Bumetanide and Scopolamine
Catry Emilie
, Colsoul Marie-Louise, Closset Melanie, Hubert Justine, Soumoy Laura, Bihin Benoit, Thiry Emmanuell, Jamart Jacques, Hecq Jean-Daniel, Galanti Laurence
May/Jun 2022
Pg. 248-254

Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
Nov/Dec 2003
Pg. 449-450

Return to Top